Comparative Analysis of ERCP and PTBD for Biliary Interventions for Readmission Rates and Patient Outcomes

Daniel Wang,Patrick Chang, Supisara Tintara, Frederick Chang,Jennifer Phan

crossref(2024)

引用 0|浏览0
暂无评分
摘要
Abstract Background Endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD) are interventions used to relieve biliary obstruction. The utility of ERCP compared to PTBD is not fully understood from a utilization outcome standpoint. Our study compares readmission rates and hospitalization outcomes in ERCP and PTBD. Methods Using the National Readmission Database (NRD) 2016–2020, we identified all patients with an ERCP or PTBD completed during admission. The study cohort was first analyzed by three weighted study arms including those admitted with cholangitis, biliary/pancreatic malignancy, and choledocholithiasis. Second, we analyzed the cohort by a 1:1, unweighted propensity match. Primary outcome was 30 day, 90 day, and 6 month readmission. Secondary outcomes were readmission/overall mortality, cost, and length of stay. Outcomes were analyzed using multivariate analysis. Results A total of 621,735 admissions were identified associated with 589,796 ERCP and 31,939 PTBD. In the propensity matched cohort, PTBD had a higher readmission rate at 30 days (20.38% vs 13.71% p < 0.0001), 90 days (14.63% vs 13.14%, p < 0.0001), but lower rate at 6 months (8.50% vs 9.67%, p = 0.0003). Secondary outcomes included increased PTBD-associated hospital length of stay (9.01 days vs 6.74 days, p < 0.0001), hospitalization cost ($106,947.97 vs $97602.25, p < 0.0001), and overall mortality (6.86% vs 4.35%, p < 0.0001). No major differences were found for mortality among readmissions at 30 days (7.19% vs 6.88%, p = 0.5382), 90 day (6.82% vs 6.51%, p = 0.5612), and 6 months (5.08% vs 5.91%, p = 0.1744). Conclusions Although both ERCP and PTBD had no major differences in mortality among readmissions, patients who had ERCP had lower readmission rates, length of stay, and overall mortality. While ERCP may be associated with a health systems benefit in routine indications, a multi-disciplinary approach may be of benefit for complex cases.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要